Tom 5, Nr 2 (2020)
Wytyczne / stanowisko ekspertów
Opublikowany online: 2020-09-10
Wyświetlenia strony
596
Wyświetlenia/pobrania artykułu
138
Stanowisko Zespołu Ekspertów Polskiego Towarzystwa Ginekologów i Położników dotyczące wyrobu medycznego Infectvagin
Ginekologia i Perinatologia Praktyczna 2020;5(2):98-101.
Streszczenie
Brak
Referencje
- Wielgos M, Pietrzak B. Bacterial vaginosis — diagnostyka i leczenie. Przegl Menopauz. 2012; 5: 356–363.
- Sieroszewski P, Bober Ł, Kłosiński W. Zakażenia podczas ciąży. Perinat Neonatol Ginekol. 2012; 5: 65–84.
- Romanik M, Ekiel A, Tomana L, et al. Waginoza bakteryjna - problemy w terapii. Wiad Lek. 2007; 60: 64–67.
- Romanik M, Wojciechowska-Wieja A, Martirosian G. Zapalenie pochwy powodowane przez bakterie tlenowe — problemy diagnostyki i leczenie. Ginekol Pol. 2007; 78: 488–491.
- Romanik M, Martirosian G. Częstość występowania, kryteria diagnostyczne i następstwa bakteryjnego zakażenia pochwy u kobiet ciężarnych. Przegl Epidemiol. 2004; 58: 547–553.
- Drews K, et al. Stanowisko Zespołu Ekspertów Polskiego Towarzystwa Ginekologicznego dotyczące produktu leczniczego Fluomizin. Ginekol Pol. 2013; 84: 237–239.
- Nalewczyńska A, Cendrowska A, Kowalska J, et al. Zaburzenia biocenozy pochwy — postępowanie diagnostyczne oraz leczenie. Ginekol Prakt. 2009; 3: 33–369.
- Zimmer M, Huras H, Kaminski P, et al. Polish Society of Gynecologists and Obstetricians recommendation on the use of antiseptics for treatment of inflammatory vaginitis. Ginekol Pol. 2020; 91(2): 432–437.
- Mahado D, et al. Bacterial Vaginosis Biofilms: Challenges to Current Therapies and Emerging Solutions. Frontiers in Microbiology. 2016; 6(1528).
- Marchaim D, Lemanek L, Bheemreddy S, et al. Fluconazole-Resistant Candida albicans Vulvovaginitis. Obstetrics & Gynecology. 2012; 120(6): 1407–1414.
- Marelli G, et al. Polyhexamethylene biguanide for treatment of external genital warts: a prospective, double-blind, randomized study. Medical and Pharmacological Sciences. 2005; 9: 369–372.
- Gerli S, Rossetti D, Di Renzo GC. A new approach for the treatment of bacterial vaginosis: use of polyhexamethylene biguanide. A prospective, randomized study. Eur Rev Med Pharmacol Sci. 2003; 7(5): 127–130.
- Koban I, Bender CP, Assadian O, et al. Clinical Use of the Antiseptic Polihexanide for Genital Tract Infections. Skin Pharmacology and Physiology. 2012; 25(6): 298–304.
- Hansmann F, Kramer A, Ohgke H, et al. Lavasept as an alternative to PVP-iodine as a preoperative antiseptic in ophthalmic surgery. Randomized, controlled, prospective double-blind trial. Ophthalmologe. 2005; 102(11): 1043–1050.
- Rosin M, Welk A, Bernhardt O, et al. Effect of a polyhexamethylene biguanide mouthrinse on bacterial counts and plaque. Journal of Clinical Periodontology. 2001; 28(12): 1121–1126.
- Ikeda T, Ledwith A, Bamford CH, et al. Interaction of a polymeric biguanide biocide with phospholipid membranes. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1984; 769(1): 57–66.
- Yasuda K, Ohmizo C, Katsu T. Potassium and tetraphenylphosphonium ion-selective electrodes for monitoring changes in the permeability of bacterial outer and cytoplasmic membranes. Journal of Microbiological Methods. 2003; 54(1): 111–115.
- Gabriel G, Som A, Madkour A, et al. Infectious disease: Connecting innate immunity to biocidal polymers. Materials Science and Engineering: R: Reports. 2007; 57(1-6): 28–64.
- Gilbert P, Moore LE. Cationic antiseptics: diversity of action under a common epithet. Journal of Applied Microbiology. 2005; 99(4): 703–715.
- Kaehn K. Polihexanide: A Safe and Highly Effective Biocide. Skin Pharmacology and Physiology. 2010; 23(1): 7–16.
- Hübner NO, Kramer A. Review on the Efficacy, Safety and Clinical Applications of Polihexanide, a Modern Wound Antiseptic. Skin Pharmacology and Physiology. 2010; 23(1): 17–27.
- Ikeda T, Tazuke S, Watanabe M. Interaction of biologically active molecules with phospholipid membranes. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1983; 735(3): 380–386.
- Ikeda T, Tazuke S, Bamford C, et al. Spectroscopic Studies on the Interaction of Polymeric In-chain Biguanide Biocide with Phospholipid Membranes as Probed by 8-Anilinonaphthalene-l-sulfonate. Bulletin of the Chemical Society of Japan. 1985; 58(2): 705–709.
- Minozzi M, et al. The efficacy and safety of a single dose of Polyhexamethylene Biguanide gynaecologic solution versus a seven-dose regimen of vaginal clindamycin cream in patients with bacterial vaginosis, European Review. Medical and Pharmacological Sciences. 2008; 12: 59–65.
- Kramer A, Roth B, Müller G, et al. Influence of the Antiseptic Agents Polyhexanide and Octenidine on FL Cells and on Healing of Experimental Superficial Aseptic Wounds in Piglets. Skin Pharmacology and Physiology. 2004; 17(3): 141–146.
- Schnuch A, et al. The biocide polyhexamethylene biguanide remains an uncommon contact alergen. Contact Dermatitis. 2007; 56(4): 235–259.
- Pelletier C, Bouley C, Cayuela C, et al. Cell surface characteristics of Lactobacillus casei subsp. casei, Lactobacillus paracasei subsp. paracasei, and Lactobacillus rhamnosus strains. Appl Environ Microbiol. 1997; 63(5): 1725–1731.
- Gentile A, et al. A new non-invasive approach based on polyhexamethylene biguanide increases the regression rate of HPV infection. BMC Clinical Pathology. 2012; 12(17).
- Instrukcja używania wyrobu medycznego Infectvagin.
- Improda L, et al. Leczenie nadżerki szyjki macicy za pomocą PHMB i żelatyny wieprzowej, Wydział Nauk Położniczo-Ginekologicznych Urologicznych i Medycyny Rozrodu Uniwersytet “Federico II” w Neapolu. Patologia Narządów Płciowych Zakaźna i Nowotworowa. 2012; 1: 20–23.
- Harnoss JC, et al. Irritative potency of selected wound antiseptics in the hen ’s egg test on chorioallantoic membrane to predict their compatibility to wounds. Wound Rep Reg. 2019; 27: 183.
- Chen J. Evaluation of the carcinogenic potential of PHMB. Office of Prevention, Pesticides, and Toxic Substances. : 2003.
- Poly(hexamethylenebiguanide) hydrochloride (PHMB) – Case 3122. Toxicology disciplinary chapter for the reregistration eligibility decision document. Environmental Protection Agency document -HQ-OPP-2004-0305-0008. EPA. : 2004.
- Environmental Protection Agency (EPA). Dictionary of Marketing Communications. .
- Poly(hexamethylenebiguanide) hydrochloride (PHMB): preliminary risk assessment for the reregistration eligibility decision (OPPTS 248.4000). Environmental Protection Agency document -HQ-OPP-2004-0305-0004. EPA. : 2004.
- Reregistration eligibility decision (RED) for PHMB. Environmental Protection Agency document -HQ-OPP-2004-0305-004. EPA. : 2004.
- Kramer A, et al. Re-evaluation of polihexanide use in wound antisepsis in order to clarify ambiguities of two animal studies. Journal Of Wound Care. 28; 4.
